CME Activities
CLICK ON STATES TO SEE LOCAL AND NATIONAL CME PROGRAMS.
(since they are not all just grand rounds)
ONLINE ACTIVITIES
SmartCast Podcast Series: Improving Outcomes in Patients with Familial Hypercholesterolemia: A Focus on Earlier Diagnosis, Treatment Selection, and Multi-Disciplinary Care
Podcast 1
Familial Hypercholesterolemia: Treatment Considerations in the Pediatric Population
(Pediatric Cardiology Track) Podcast 2
Familial Hypercholesterolemia: Background, Burden, and Early Treatment
(Pediatric Cardiology Track) Podcast 3
Familial Hypercholesterolemia: Early vs. later intervention and implications for long-term outlook
(Managed Care Track) Podcast 4
Familial Hypercholesterolemia: Treatment Considerations for the Managed Care Professional
(Managed Care Track) Podcast 5
Familial Hypercholesterolemia: Background, Burden, and Early Treatment
(Infusion Center Track) Podcast 6
Familial Hypercholesterolemia: Treatment Considerations for the Infusion Center Professional
(Infusion Center Track)
RELEASED DATE: July 14, 2023
EXPIRATION DATE: August 15, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
Whiteboard Micro-Learning Series: Improving Outcomes in Patients with Familial Hypercholesterolemia: A Focus on Earlier Diagnosis, Treatment Selection, and Multi-Disciplinary Care
FACULTY
Geoffrey C. Wall, PharmD, FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
LEARNING OBJECTIVES
- Interpret the unique treatment needs of patients with FH along with their increased risk for ACVD in the short and long term.
- Evaluate evidence from clinical trials on therapies for the treatment of patients with FH including long-term CV outcomes
- Review the cost and efficacy considerations for FH formulary options such as switching and/or maximizing statins, and implementing newly approved drugs and combinations
TARGET AUDIENCE
This initiative is designed to meet the educational needs of pediatricians, pediatric and general cardiologists, lipidologists, infusion center specialists, managed care pharmacy professionals, and other clinical workers involved in the management of patients with familial hypercholesterolemia (FH).
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT (ACCME)
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 0.25 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
| Geoffrey C. Wall, PharmD | Reports that he has served on the speaker’s bureau for Janssen Pharmaceutical and La Jolla Pharmaceuticals. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Chris Drury, MA, MS, MBA, Scientific and Medical Services for Med Learning Group has nothing to disclose.
- Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
- Amanda Jenkins, Program Manager for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Daniel DaSilva, Outcomes and Accreditation Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
RELEASED DATE: August 15, 2023
EXPIRATION DATE: August 15, 2024
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
Virtual Reality Learning Room Activities
GRAND ROUNDS
BOOTH TOUR
A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
